ImmunoMind

Berkeley, United States

Multi-Omics Driven Development of Effective Cell Therapies

$150K raised

Jan 2022

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ImmunoMind raised?

ImmunoMind has raised $150K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2022.

Who are ImmunoMind's investors?

ImmunoMind's investors include SkyDeck Berkeley.

Where is ImmunoMind headquartered?

ImmunoMind is headquartered in Berkeley, United States.

What does ImmunoMind do?

Multi-Omics Driven Development of Effective Cell Therapies

What stage is ImmunoMind at?

ImmunoMind is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2022.

MLA

"ImmunoMind — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/immunomind. Accessed July 2, 2026.

APA

VCBacked. (2022). ImmunoMind — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/immunomind

Wikipedia (cite web)

{{cite web |title=ImmunoMind — Funding & Investors |url=https://www.vcbacked.co/company/immunomind |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2022.